NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
02/04/2025
Back to search
Official data from USPTO
OBSIDIO
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
39
Latest update
02/04/2025
Trademark type
Word
Nice classes
5, 10
Filing date
10/25/2022
Registration date
02/04/2025
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
02/04/2025
Last transaction
02/04/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
2023-05-00
First use in commerce
2023-05-00
Drawing code
4
Owner type
03
Owner location
Maple Grove, MN, US
Examiner
DAWE III, BILL
Law office
L80
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Boston Scientific Scimed, Inc.
Representatives
Lori A. Ruhly Quarles & Brady LLP
Technical classification
Nice Classes
Class 5Class 10
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations for implantable hydrogel-based embolics; pharmaceutical preparationsembolization therapy preparations for embolization of tumors; medical preparations for embolization therapy systems for the treatment of hypervascular tumors and blood vessels to stop blood flow and control bleeding and hemorrhaging; medical preparations for vascular embolizationhemorrhage controlperipheral hemostasis; medical preparations used for embolization of vascular lesionstumorstargeted arterial segments of hypervascular tumorscontrol of bleeding due to disease or traumaorgans and segmental embolizations; pharmaceutical preparationsdifferentiated liquid embolic agents for embolization of hypervascular tumors and blood vessels to stop blood flow and control bleeding and hemorrhaging; pharmaceutical preparations for medical and surgical purposes in the nature of implantable materials comprised of artificial materialshydrogels; pharmaceutical preparations for embolization therapy in interventional radiology and oncology in the nature of implants comprised of artificial materialshydrogels; medical preparations for embolization therapy in interventional radiology and oncology in the nature of implants comprised of artificial materialshydrogels; preparations for implantable surgical materials in the nature of implants comprised of artificial materialshydrogels
Class 10
Surgical and medical apparatus and instruments for use in general surgery; medical apparatus and instruments for use in embolization surgery; medical devicearterial embolectomy device in the nature of catheters for use in embolectomy; medical device for embolization therapy in interventional radiology and oncology; embolic devices for interventional radiologyinterventional oncology and peripheral hemostasis; medical device for vascular embolization procedures; medical device used for embolization of vascular lesionstumorstargeted arterial segments of hypervascular tumorscontrol of bleeding due to disease or traumaorgans and segmental embolizations; medical devicessyringes and delivery catheters for the delivery of embolic agents delivered through a microcatheter under fluoroscopic control; medical apparatussystem for vascular embolization procedures in the nature of catheters for use in embolectomy
Publications
History of USPTO decisions and trademark events.
39 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
02/04/2025
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
01/14/2025
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
01/14/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
01/14/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/14/2025
ALIE
ASSIGNED TO LIE
01/13/2025
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
12/12/2024
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
09/16/2024
GNRT
NON-FINAL ACTION E-MAILED
09/16/2024
CNRT
SU - NON-FINAL ACTION - WRITTEN
09/16/2024
SUPC
STATEMENT OF USE PROCESSING COMPLETE
09/13/2024
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
09/11/2024
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
09/03/2024
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
09/03/2024
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
09/03/2024
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
09/03/2024
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
09/03/2024
IUAF
USE AMENDMENT FILED
07/10/2024
EISU
TEAS STATEMENT OF USE RECEIVED
07/10/2024
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
01/16/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
11/21/2023
PUBO
PUBLISHED FOR OPPOSITION
11/21/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
11/01/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
10/12/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/04/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/04/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
10/04/2023
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
07/13/2023
GNRT
NON-FINAL ACTION E-MAILED
07/13/2023
CNRT
NON-FINAL ACTION WRITTEN
07/13/2023
DOCK
ASSIGNED TO EXAMINER
07/12/2023
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
03/16/2023
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
03/16/2023
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
03/16/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
03/16/2023
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
03/16/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
11/08/2022
NWAP
NEW APPLICATION ENTERED
10/28/2022
Continuous trademark protection
Get notified about every new filing that threatens OBSIDIO or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.